Health effects of nutrients and environmental pollutants in Baltic herring and salmon: a quantitative benefit-risk assessment

被引：0
|
作者：
Jouni T. Tuomisto
Arja Asikainen
Päivi Meriläinen
Päivi Haapasaari
机构：
[1] Finnish Institute for Health and Welfare,
[2] University of Helsinki,undefined
来源：
BMC Public Health | / 20卷
关键词：
Fish consumption; Dioxins; Methylmercury; Benefit-risk assessment; Health impact; Sperm concentration; Baltic Sea; Knowledge crystal; Food recommendation; European food safety authority EFSA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Health effects of nutrients and environmental pollutants in Baltic herring and salmon: a quantitative benefit-risk assessment
    Tuomisto, Jouni T.
    Asikainen, Arja
    Merilainen, Paivi
    Haapasaari, Paivi
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [2] On a Stepwise Quantitative Approach for Benefit-Risk Assessment
    He, Weili
    Sun, Yaxuan
    Li, Qing
    Wan, Sabrina
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (05) : 625 - 634
  • [3] On a Stepwise Quantitative Approach for Benefit-Risk Assessment
    Weili He
    Yaxuan Sun
    Qing Li
    Sabrina Wan
    [J]. Therapeutic Innovation & Regulatory Science, 2017, 51 : 625 - 634
  • [4] Structured benefit-risk evaluation for medicinal products: review of quantitative benefit-risk assessment findings in the literature
    Kurzinger, Marie-Laure
    Douarin, Ludivine
    Uzun, Ievgeniia
    El-Haddad, Chantal
    Hurst, William
    Juhaeri, Juhaeri
    Tcherny-Lessenot, Stephanie
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [5] A Quantitative Approach to Benefit-Risk Assessment: An Example with Lumiracoxib
    Primatesta, Paola
    Plana, Estel
    Moore, Alan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S139 - S139
  • [6] Quantitative benefit-risk assessment: Hands-on workshop
    Ataher, Quazi S.
    Postmus, Douwe
    Hillege, Hans L.
    Tervonen, Tommi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 360 - 360
  • [7] Semi-Quantitative Benefit-Risk Assessment for Dengvaxia
    Marcelon, Lydie F.
    Cohen, Carine H.
    Khromava, Alena
    Ochiai, Leon R.
    Wartel, Anh T.
    Gailhardou, Sophia
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 289 - 290
  • [8] State of the art in benefit-risk analysis: Environmental health
    Pohjola, M. V.
    Leino, O.
    Kollanus, V.
    Tuomisto, J. T.
    Gunnlaugsdottir, H.
    Holm, F.
    Kalogeras, N.
    Luteijn, J. M.
    Magnusson, S. H.
    Odekerken, G.
    Tijhuis, M. J.
    Ueland, O.
    White, B. C.
    Verhagen, H.
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2012, 50 (01) : 40 - 55
  • [9] Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
    Caster, Ola
    Edwards, I. Ralph
    [J]. BMC NEUROLOGY, 2015, 15
  • [10] Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
    Ola Caster
    I. Ralph Edwards
    [J]. BMC Neurology, 15
12345